Multi-analyte profiling in human carotid atherosclerosis uncovers pro-inflammatory macrophage programming in plaques

Summary

Molecular characterisation of vulnerable atherosclerosis is necessary for targeting functional imaging and plaque-stabilising therapeutics. Inflammation has been linked to atherogenesis and the development of high-risk plaques. We set to quantify cytokine, chemokine and matrix metalloproteinase (MMP) protein production in cells derived from carotid plaques to map the inflammatory milieu responsible for instability. Carotid endarterectomies from carefully characterised symptomatic (n=35) and asymptomatic (n=32) patients were enzymatically dissociated producing mixed cell type atheroma cell suspensions which were cultured for 24 hours. Supernatants were interrogated for 45 analytes using the Luminex 100 platform. Twenty-nine of the 45 analytes were reproducibly detectable in the majority of donors. The in vitro production of a specific network of mediators was found to be significantly higher in symptomatic than asymptomatic plaques, including: tumour necrosis factor α, interleukin (IL) 1β, IL-6, granulocytemacrophage colony-stimulating factor (GM-CSF), macrophage colonystimulating factor (M-CSF), CCL5, CCL20, CXCL9, matrix metalloproteinase (MMP)-3 and MMP-9. Ingenuity pathway analysis of differentially expressed analytes between symptomatic and asymptomatic patients identified a number of key biological pathways (p > 10^–25). In conclusion, the carotid artery plaque culprit of ischaemic neurological symptoms is characterised by an inflammatory milieu favouring inflammatory cell recruitment and pro-inflammatory macrophage polarisation.

Supplementary Material to this article is available online at www.thrombosis-online.com.

Keywords

Atherosclerosis - carotid stenosis - inflammation - cytokines

^* Current affiliation: BioMediTech, University of Tampere, 33014, Tampere, Finland.

• References

• 1 Full L, Ruisanchez C, Monaco C. The inextricable link between atherosclerosis and prototypical inflammatory diseases rheumatoid arthritis and systemic lupus erythematosus. Arthritis Res Ther 2009; 11: 217.
• 2 Weber C, Zernecke A, Libby P. The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models. Nat Rev Immunol 2008; 8: 802-815.
• 3 Davies MJ, Richardson PD, Woolf N. et al. Risk of thrombosis in human atherosclerotic plaques: role of extracellular lipid, macrophage, and smooth muscle cell content. Br Heart J 1993; 69: 377-381.
• 4 Virmani R, Burke AP, Farb A. et al. Pathology of the vulnerable plaque. J Am Coll Cardiol 2006; 47 (08) Suppl C13-C18.
• 5 van der Wal AC, Becker AE, van der Loos CM. et al. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 1994; 89: 36-44.
• 6 Mantovani A, Sica A, Sozzani S. et al. The chemokine system in diverse forms of macrophage activation and polarisation. Trends Immunol 2004; 25: 677-686.
• 7 Gordon S, Martinez FO. Alternative activation of macrophages: mechanism and functions. Immunity 2010; 32: 593-604.
• 8 Michelsen KS, Wong MH, Shah PK. et al. Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E. Proc Natl Acad Sci USA 2004; 101: 10679-10684.
• 9 Gupta S, Pablo A, Jiang X. et al. IFN-gamma potentiates atherosclerosis in ApoE knock-out mice. J Clin Invest 1997; 99: 2752-2761.
• 10 Khallou-Laschet J, Varthaman A, Fornasa G. et al. Macrophage plasticity in experimental atherosclerosis. PLoS One 2010; 5: e8852.
• 11 Seneviratne AN, Cole JE, Goddard ME. et al. Low shear stress induces M1 macrophage polarisation in murine thin-cap atherosclerotic plaques. J Mol Cell Cardiol. 2015 Epub ahead of print.
• 12 Stoger JL, Gijbels MJ, van der Velden S. et al. Distribution of macrophage polarisation markers in human atherosclerosis. Atherosclerosis 2012; 225: 461-468.
• 13 Bouhlel MA, Derudas B, Rigamonti E. et al. PPARgamma activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties. Cell Metab 2007; 6: 137-143.
• 14 Hirata Y, Tabata M, Kurobe H. et al. Coronary atherosclerosis is associated with macrophage polarisation in epicardial adipose tissue. J Am Coll Cardiol 2011; 58: 248-255.
• 15 Shaikh S, Brittenden J, Lahiri R. et al. Macrophage subtypes in symptomatic carotid artery and femoral artery plaques. Eur J Vasc Endovasc Surg 2012; 44: 491-497.
• 16 Monaco C, Andreakos E, Kiriakidis S. et al. Canonical pathway of nuclear factor kappa B activation selectively regulates proinflammatory and prothrombotic responses in human atherosclerosis. Proc Natl Acad Sci USA 2004; 101: 5634-5639.
• 17 Monaco C, Gregan SM, Navin TJ. et al. Toll-like receptor-2 mediates inflammation and matrix degradation in human atherosclerosis. Circulation 2009; 120: 2462-2469.
• 18 Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 65: 55-63.
• 19 Benjamini Y, Hochberg Y. Controlling the False Discovery Rate: A practical and powerful approach to multiple testing. J Royal Stat Soc B 1995; 57: 289-300.
• 20 Szklarczyk D, Franceschini A, Wyder S. et al. STRING v10: protein-protein interaction networks, integrated over the tree of life. Nucleic Acids Res 2015; 43 (Database issue) D447-D452.
• 21 Lawrence T, Natoli G. Transcriptional regulation of macrophage polarisation: enabling diversity with identity. Nat Rev Immunol 2011; 11: 750-761.
• 22 Guedj K, Khallou-Laschet J, Clement M. et al. Inflammatory micro-environmental cues of human atherothrombotic arteries confer to vascular smooth muscle cells the capacity to trigger lymphoid neogenesis. PLoS ONE 2014; 9: e116295.
• 23 Manthey HD, Cochain C, Barnsteiner S. et al. CCR6 selectively promotes monocyte mediated inflammation and atherogenesis in mice. Thromb Haemost 2013; 110: 1267-1277.
• 24 Martinez FO, Gordon S, Locati M. et al. Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarisation: new molecules and patterns of gene expression. J Immunol 2006; 177: 7303-7311.
• 25 Guedj K, Khallou-Laschet J, Clement M. et al. M1 macrophages act as LTβR-independent lymphoid tissue inducer cells during atherosclerosis-related lymphoid neogenesis. Cardiovasc Res 2014; 101: 434-443.
• 26 Liuzzo G, Vallejo AN, Kopecky SL. et al. Molecular fingerprint of interferongamma signalling in unstable angina. Circulation 2001; 103: 1509-1514.
• 27 Kadl A, Meher AK, Sharma PR. et al. Identification of a novel macrophage phenotype that develops in response to atherogenic phospholipids via Nrf2. Circ Res 2010; 107: 737-746.
• 28 Murray PJ, Allen JE, Biswas SK. et al. Macrophage activation and polarisation: nomenclature and experimental guidelines. Immunity 2014; 41: 14-20.
• 29 Pasterkamp G, Schoneveld AH, Hijnen DJ. et al. Atherosclerotic arterial remodeling and the localisation of macrophages and matrix metalloproteases 1, 2 and 9 in the human coronary artery. Atherosclerosis 2000; 150: 245-253.
• 30 Hayes EM, Tsaousi A, Di Gregoli K. et al. Classical and Alternative Activation and Metalloproteinase Expression Occurs in Foam Cell Macrophages in Male and Female ApoE Null Mice in the Absence of T and B Lymphocytes. Front Immunol 2014; 5: 537.
• 31 Shalhoub J, Monaco C, Owen DR. et al. Late-phase contrast-enhanced ultrasound reflects biological features of instability in human carotid atherosclerosis. Stroke 2011; 42: 3634-3636.